Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

August 13, 2025

Study Completion Date

August 14, 2025

Conditions

BleedingContraceptive Device; Complications

Interventions

DRUG

Tranexamic acid

1300mg TXA taken three times per day for five days

OTHER

Placebo

Placebo pills taken three times daily for five days.

Trial Locations (1)

Oregon Health & Science University, Portland

All Listed Sponsors

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Oregon Health and Science University

OTHER

NCT06000423 - Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects | Biotech Hunter | Biotech Hunter